Functional rna and small-molecule drug therapeutic complexes and nanoparticle delivery vehicles
AssigneeEos Biosciences, Inc.
InventorOmar K. HAFFAR
Life of this patent
Estimating the term…
Loading patent…
AssigneeEos Biosciences, Inc.
InventorOmar K. HAFFAR
Estimating the term…
Disclosed herein are therapeutic complexes comprising a small-molecule drug complexed with a functional RNA. Further disclosed herein are compositions comprising nanoparticles comprising a carrier polypeptide and a functional RNA molecule complexed with a small-molecule drug, wherein the carrier polypeptide comprises a cell-targeting segment, a cell-penetrating segment, and an oligonucleotide-binding segment, along with methods of making and using such nanoparticles. Further described are methods of treating a subject with a cancer, comprising administering to the subject an effective amount of a composition comprising nanoparticles, the nanoparticles comprising a carrier polypeptide and a functional RNA molecule complexed with a small-molecule chemotherapeutic drug, wherein the carrier polypeptide comprises a cell-targeting segment, a cell-penetrating segment, and an oligonucleotide-binding segment. Also described are pharmaceutical compositions, articles of manufacture, and kits comprising the described nanoparticles.
A composition, comprising a functional RNA molecule complexed with a small-molecule drug, wherein the functional RNA molecule modulates expression of a target protein.
A composition, comprising a functional RNA molecule comprising at least one complementary region intercalated with a small-molecule drug.
A composition comprising nanoparticles comprising a carrier polypeptide and a functional RNA molecule complexed with a small-molecule drug, wherein the carrier polypeptide comprises a cell-penetrating segment and an oligonucleotide-binding segment.
A method of making a composition, comprising combining a small-molecule drug with a functional RNA molecule, wherein the small-molecule drug intercalates into the functional RNA molecule.
A method of making a nanoparticle composition comprising combining a carrier polypeptide, a functional RNA molecule, and a small-molecule drug, wherein the carrier polypeptide comprises a cell-penetrating segment and an oligonucleotide-binding segment.
Dependencies are inferred from the claim text.